<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Organogenesis Holdings Inc.

    Organogenesis Holdings Inc.

    Organogenesis Holdings Inc. is a leading regenerative medicine company focused on ...

    Organogenesis Holdings Inc. is a leading regene...

    Filing Type:    PU
    Diffusion Pharmaceuticals Inc.

    Diffusion Pharmaceuticals Inc.

    Diffusion Pharmaceuticals is a clinical stage company focused on improving the eff...

    Diffusion Pharmaceuticals is a clinical stage c...

    Filing Type:    PU
    Jazz Pharmaceuticals plc

    Jazz Pharmaceuticals plc

    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company that...

    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a gl...

    Filing Type:    PU
    SCYNEXIS, Inc.

    SCYNEXIS, Inc.

    SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the li...

    SCYNEXIS, Inc. is a biotechnology company commi...

    Filing Type:    PU
    Guardion Health Sciences, Inc.

    Guardion Health Sciences, Inc.

    Guardion Health Sciences is at the forefront of early detection, intervention and ...

    Guardion Health Sciences is at the forefront of...

    Filing Type:    PU
    Aduro Biotech, Inc.

    Aduro Biotech, Inc.

    Aduro is dedicated to its mission to discover, develop, and commercialize immunoth...

    Aduro is dedicated to its mission to discover, ...

    Filing Type:    PU
    Hutchison China MediTech Limited

    Hutchison China MediTech Limited

    Hutchison China MediTech Limited, known as Chi-Med, is an innovative biopharmaceut...

    Hutchison China MediTech Limited, known as Chi-...

    Filing Type:    PU
    Sorrento Therapeutics, Inc.

    Sorrento Therapeutics, Inc.

    Sorrento’s lead programs with short-term milestones consist of two clinical stag...

    Sorrento’s lead programs with short-term mile...

    Filing Type:    PU
    Compugen Ltd.

    Compugen Ltd.

    Compugen is a drug discovery company with a unique, broadly applicable, predictive...

    Compugen is a drug discovery company with a uni...

    Filing Type:    PU
    Calithera Biosciences, Inc.

    Calithera Biosciences, Inc.

    Calithera is a clinical-stage biopharmaceutical company pioneering the discovery a...

    Calithera is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Idera Pharmaceuticals, Inc.

    Idera Pharmaceuticals, Inc.

    Idera Pharmaceuticals is a clinical-stage biopharmaceutical company developing nov...

    Idera Pharmaceuticals is a clinical-stage bioph...

    Filing Type:    PU
    NeoGenomics, Inc.

    NeoGenomics, Inc.

    NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory and phar...

    NeoGenomics, Inc. is a high-complexity CLIA-cer...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.